Next Generation
TRPV1 Modulation
AazeinTx is the global leader in next generation TRPV1 modulation, targeting neuroinflammatory diseases with a novel peripherally acting TRPV1 immuno-modulator.
AazeinTx is the global leader in next generation TRPV1 modulation, targeting neuroinflammatory diseases with a novel peripherally acting TRPV1 immuno-modulator.
The TRPV1 receptor plays a parallel role in inflammation & local inflammation that activates the nervous system. This in turn exacerbates inflammation, leading to organ-specific dysfunction.
Our science has an extensive safety database in 118 humans. Second generation TRPV1 modulation preserves channel abilities.
We have a robust IP profile in North America and abroad. Patents are issued/pending in most global jurisdictions.
The science behind AazeinTx is de-risked with outstanding data in a gold-standard pre-clinical model.